Schrag A - Search Results

1

Health-related quality-of-life scales in Parkinson's disease: critique and recommendations.

Martinez-Martin P, Jeukens-Visser M, Lyons KE, Rodriguez-Blazquez C, Selai C, Siderowf A, Welsh M, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG, Schrag A. Martinez-Martin P, et al. Among authors: schrag a. Mov Disord. 2011 Nov;26(13):2371-80. doi: 10.1002/mds.23834. Epub 2011 Jul 6. Mov Disord. 2011. PMID: 21735480 Review.

2

The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.

Schrag AE, Brooks DJ, Brunt E, Fuell D, Korczyn A, Poewe W, Quinn NP, Rascol O, Stocchi F. Schrag AE, et al. Clin Neuropharmacol. 1998 May-Jun;21(3):169-75. Clin Neuropharmacol. 1998. PMID: 9617508 Clinical Trial.

3

Reduction of Parkinsonian signs in patients with Parkinson's disease by dopaminergic versus anticholinergic single-dose challenges.

Schrag A, Schelosky L, Scholz U, Poewe W. Schrag A, et al. Mov Disord. 1999 Mar;14(2):252-5. doi: 10.1002/1531-8257(199903)14:2<252::aid-mds1009>3.0.co;2-n. Mov Disord. 1999. PMID: 10091618 Clinical Trial.

4

Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease.

Hagell P, Crabb L, Pogarell O, Schrag A, Widner H, Brooks DJ, Oertel WH, Quinn NP, Lindvall O. Hagell P, et al. Among authors: schrag a. Mov Disord. 2000 Mar;15(2):224-9. doi: 10.1002/1531-8257(200003)15:2<224::aid-mds1004>3.0.co;2-w. Mov Disord. 2000. PMID: 10752570

5

The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.

Schrag A, Selai C, Jahanshahi M, Quinn NP. Schrag A, et al. J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):67-73. doi: 10.1136/jnnp.69.1.67. J Neurol Neurosurg Psychiatry. 2000. PMID: 10864606 Free PMC article.

6

How does Parkinson's disease affect quality of life? A comparison with quality of life in the general population.

Schrag A, Jahanshahi M, Quinn N. Schrag A, et al. Mov Disord. 2000 Nov;15(6):1112-8. doi: 10.1002/1531-8257(200011)15:6<1112::aid-mds1008>3.0.co;2-a. Mov Disord. 2000. PMID: 11104193

7

Quality of life in stiff-person syndrome.

Gerschlager W, Schrag A, Brown P. Gerschlager W, et al. Among authors: schrag a. Mov Disord. 2002 Sep;17(5):1064-7. doi: 10.1002/mds.10235. Mov Disord. 2002. PMID: 12360560

8

Young- versus older-onset Parkinson's disease: impact of disease and psychosocial consequences.

Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M. Schrag A, et al. Mov Disord. 2003 Nov;18(11):1250-6. doi: 10.1002/mds.10527. Mov Disord. 2003. PMID: 14639664

9

Sweating dysfunction in Parkinson's disease.

Swinn L, Schrag A, Viswanathan R, Bloem BR, Lees A, Quinn N. Swinn L, et al. Among authors: schrag a. Mov Disord. 2003 Dec;18(12):1459-63. doi: 10.1002/mds.10586. Mov Disord. 2003. PMID: 14673882

10

Health-related quality of life in patients with progressive supranuclear palsy.

Schrag A, Selai C, Davis J, Lees AJ, Jahanshahi M, Quinn N. Schrag A, et al. Mov Disord. 2003 Dec;18(12):1464-9. doi: 10.1002/mds.10583. Mov Disord. 2003. PMID: 14673883

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

364 results

Search Page

Filters